These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 28233153)

  • 1. Phenotype-Driven Therapeutics in Severe Asthma.
    Opina MT; Moore WC
    Curr Allergy Asthma Rep; 2017 Feb; 17(2):10. PubMed ID: 28233153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroids: still at the frontline in asthma treatment?
    Louis R; Schleich F; Barnes PJ
    Clin Chest Med; 2012 Sep; 33(3):531-41. PubMed ID: 22929100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling the Risk Domain in Pediatric Asthma through Personalized Care.
    Anderson WC; Szefler SJ
    Semin Respir Crit Care Med; 2018 Feb; 39(1):36-44. PubMed ID: 29427984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, open labeled, comparative study to assess the efficacy and safety of controller medications as add on to inhaled corticosteroid and long-acting β2 agonist in the treatment of moderate-to-severe persistent asthma.
    Patel YA; Patel P; Bavadia H; Dave J; Tripathi CB
    J Postgrad Med; 2010; 56(4):270-4. PubMed ID: 20935397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting beta-agonist treatment in patients with persistent asthma already receiving inhaled corticosteroids.
    Hancox RJ; Taylor DR
    BioDrugs; 2001; 15(1):11-24. PubMed ID: 11437672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-line controller therapy for persistent asthma uncontrolled on inhaled corticosteroids: the step 3 dilemma.
    Lipworth BJ; Jackson CM
    Drugs; 2002; 62(16):2315-32. PubMed ID: 12396225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to prevent exacerbations of childhood asthma.
    Peloza DL; Jackson DJ
    Curr Opin Pulm Med; 2019 Jan; 25(1):27-33. PubMed ID: 30422897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual components of optimal asthma therapy: scientific and clinical rationale for the use of long-acting beta-agonists with inhaled corticosteroids.
    Naedele-Risha R; Dorinsky P; Craig TJ
    J Am Osteopath Assoc; 2001 Sep; 101(9):526-33. PubMed ID: 11575039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
    Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe asthma in school-age children: evaluation and phenotypic advances.
    Coverstone A; Bacharier LB; Fitzpatrick AM
    Curr Allergy Asthma Rep; 2015 May; 15(5):20. PubMed ID: 26134431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based pharmacologic treatment for mild asthma.
    Koh MS; Irving LB
    Int J Clin Pract; 2007 Aug; 61(8):1375-9. PubMed ID: 17590220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for phenotype-driven treatment in asthmatic patients.
    Gonem S; Desai D; Siddiqui S; Brightling CC
    Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):381-5. PubMed ID: 21670666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of standard pharmacological therapy for adult asthma – Steps 1 to 5.
    Patel M; Shaw D
    Chron Respir Dis; 2015 May; 12(2):165-76. PubMed ID: 25711467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing severe asthma in adults: lessons from the ERS/ATS guidelines.
    Chung KF
    Curr Opin Pulm Med; 2015 Jan; 21(1):8-15. PubMed ID: 25405672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma.
    Chantaphakul H; Ruxrungtham K
    Expert Opin Pharmacother; 2016; 17(5):631-42. PubMed ID: 26799114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies and opportunities in severe asthma.
    Humbert M; Busse W; Hanania NA
    Curr Opin Pulm Med; 2018 Jan; 24(1):83-93. PubMed ID: 29059087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary therapy in asthma: inhaled corticosteroids and what?
    Bjermer L; Diamant Z
    Curr Opin Pulm Med; 2009 Jan; 15(1):46-51. PubMed ID: 19077705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of bronchial asthma.
    Nelson HS
    Allergy Asthma Proc; 2001; 22(4):217-20. PubMed ID: 11552671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.